Literature DB >> 18678928

Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beams.

Gabriel O Sawakuchi1, Uwe Titt, Dragan Mirkovic, Radhe Mohan.   

Abstract

Density heterogeneities in the path of proton beams are known to cause degradation of the Bragg peak and, thus, widening of its distal fall-off. Inadequate accounting for this effect may lead to unwanted dose delivered to normal tissue distal to the target volume. In low-density regions, such as the thorax, this may lead to large volumes of healthy tissue receiving unnecessary dose. Although it is known that multiple Coulomb scattering within the density heterogeneities is the main cause of Bragg peak degradation, no systematic attempt has been made to quantify the contribution of multiple Coulomb scattering and nuclear scattering. Through a systematic study using a 220 MeV proton beam, we show that nuclear scattering contributes to about 5% of the distal fall-off width and is only slightly dependent on heterogeneity complexity. Furthermore, we also show that the energy spectra of the proton fluence downstream of various heterogeneity volumes are well correlated with the Bragg peak distal fall-off widths. Based on this correlation, a novel method for predicting distal fall-offs is suggested. This method is tested for three clinical setups of a voxelized model of a human head based on computer tomography data. Results are within 3% of the distal fall-off values obtained using Monte Carlo simulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678928     DOI: 10.1088/0031-9155/53/17/010

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  17 in total

1.  Adjustment of the lateral and longitudinal size of scanned proton beam spots using a pre-absorber to optimize penumbrae and delivery efficiency.

Authors:  Uwe Titt; Dragan Mirkovic; Gabriel O Sawakuchi; Luis A Perles; Wayne D Newhauser; Phillip J Taddei; Radhe Mohan
Journal:  Phys Med Biol       Date:  2010-11-12       Impact factor: 3.609

2.  Degradation of proton depth dose distributions attributable to microstructures in lung-equivalent material.

Authors:  Uwe Titt; Martin Sell; Jan Unkelbach; Mark Bangert; Dragan Mirkovic; Uwe Oelfke; Radhe Mohan
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

3.  Benchmark measurements and simulations of dose perturbations due to metallic spheres in proton beams.

Authors:  Wayne D Newhauser; Laura Rechner; Dragan Mirkovic; Pablo Yepes; Nicholas C Koch; Uwe Titt; Jonas D Fontenot; Rui Zhang
Journal:  Radiat Meas       Date:  2013-11-01       Impact factor: 1.898

4.  Dosimetric accuracy of proton therapy for chordoma patients with titanium implants.

Authors:  Joost M Verburg; Joao Seco
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

5.  Validation of a GPU-based Monte Carlo code (gPMC) for proton radiation therapy: clinical cases study.

Authors:  Drosoula Giantsoudi; Jan Schuemann; Xun Jia; Stephen Dowdell; Steve Jiang; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-02-26       Impact factor: 3.609

6.  Feasibility of Using Distal Endpoints for In-room PET Range Verification of Proton Therapy.

Authors:  Kira Grogg; Xuping Zhu; Chul Hee Min; Brian Winey; Thomas Bortfeld; Harald Paganetti; Helen A Shih; Georges El Fakhri
Journal:  IEEE Trans Nucl Sci       Date:  2013-10       Impact factor: 1.679

7.  Site-specific range uncertainties caused by dose calculation algorithms for proton therapy.

Authors:  J Schuemann; S Dowdell; C Grassberger; C H Min; H Paganetti
Journal:  Phys Med Biol       Date:  2014-07-03       Impact factor: 3.609

Review 8.  Range uncertainties in proton therapy and the role of Monte Carlo simulations.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2012-05-09       Impact factor: 3.609

9.  Dosimetric impact of range uncertainty in passive scattering proton therapy.

Authors:  Ruirui Liu; Baozhou Sun; Tiezhi Zhang; Jeffery F Williamson; Joseph A O'Sullivan; Tianyu Zhao
Journal:  J Appl Clin Med Phys       Date:  2021-04-02       Impact factor: 2.102

10.  Proton Therapy: Ever Shifting Sands and the Opportunities and Obligations within.

Authors:  Christine E Hill-Kayser; Stefan Both; Zelig Tochner
Journal:  Front Oncol       Date:  2011-09-06       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.